Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder

Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder

PurposeFingolimod, an oral treatment for relapsing-remitting multiple sclerosis (RRMS), has been associated with a significant rebound in disease activity after therapy cessation. We described a patient with neuromyelitis optica spectrum disorder (NMOSD) who was previously diagnosed with RRMS and ex...

Full description

Bibliographic Details
Main Authors: Wei Lin, Chung-Hsing Chou, Fu-Chi Yang, Chia-Kuang Tsai, Yu-Kai Lin, Yueh-Feng Sung
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
fingolimod withdrawal syndrome
relapse-remitting multiple sclerosis
neuromyelitis optica spectrum disorder
fingolimod rebound syndrome
aquaporin-4 antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1115120/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1115120/full

Similar Items